Terns Pharmaceuticals News

Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares

Simply Wall StJun 15 10:11 ET

Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's Is How to Trade

Yahoo FinanceJun 4 09:55 ET

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product

GlobeNewswireJun 3 16:10 ET

Buy Rating Upheld for Terns Pharmaceuticals Amid Strong Prospects for TERN-701 and Financial Stability

TipRanksJun 2 16:45 ET

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

FOSTER CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product

GlobeNewswireMay 30 08:05 ET

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day

FOSTER CITY, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product

GlobeNewswireMay 17 16:05 ET

Optimistic Buy Rating for Terns Pharmaceuticals Amid Promising Clinical Progress and Solid Financial Footing

TipRanksMay 16 04:38 ET

Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and OptimizeRx (OPRX)

TipRanksMay 15 00:30 ET

Buy Rating Affirmed for Terns Pharmaceuticals Amid Robust Financials and Promising Pipeline Prospects

TipRanksMay 14 07:16 ET

Express News | HC Wainwright & Co. Reiterates Neutral on Terns Pharma, Maintains $5.5 Price Target

BenzingaMay 14 06:34 ET

Terns Pharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 -6.62% HC Wainwright & Co. → $5.5 Reiterates Neutral → Neutral 04/30/2024 -6.62% HC Wainwright

BenzingaMay 14 06:33 ET

Hold Rating on Terns Pharmaceuticals Pending Clinical Trial Outcomes

TipRanksMay 14 06:28 ET

Analysts Are Bullish on These Healthcare Stocks: Alphatec Holdings (ATEC), Terns Pharmaceuticals (TERN)

TipRanksMay 13 18:20 ET

Terns Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 13 16:19 ET · Announcements

Express News | Terns Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q1 GAAP EPS Results

BenzingaMay 13 10:18 ET

Terns Pharmaceuticals Inc (TERN) Q1 2024 Earnings: Misses Analyst Net Loss Projections

Yahoo FinanceMay 13 09:32 ET

Express News | Terns Pharma Q1 2024 GAAP EPS $(0.30) Beats $(0.34) Estimate

BenzingaMay 13 08:14 ET

Terns Pharmaceuticals: Runway Into 2026 >TERN

Terns Pharmaceuticals: Runway Into 2026 >TERN

Dow JonesMay 13 08:07 ET

Express News | Terns Pharmaceuticals Inc: Cash, Cash Equivalents and Marketable Securities of $241 Mln, Expected to Provide Runway Into 2026

ReutersMay 13 08:05 ET

Express News | Terns Pharmaceuticals Q1 Operating Expenses USD 25.446 Million

ReutersMay 13 08:05 ET